Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13969
Abstract: Intravenous flucloxacillin is one of the most frequently used high‐dose penicillin therapies in hospitalized patients, forming the cornerstone treatment of invasive Staphylococcus aureus infection. Being a nonreabsorbable anion, flucloxacillin has been suggested to cause hypokalaemia,… read more here.
Keywords: treatment; incidence hypokalaemia; flucloxacillin; hypokalaemia ... See more keywords
Hypokalemia in patients treated with intravenous flucloxacillin: incidence and risk factors.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15236
Abstract: INTRODUCTION Hypokalemia is a potentially life-threatening adverse event of flucloxacillin with unknown incidence. The risk of flucloxacillin-induced hypokalemia has recently been suggested to be increased among females compared to males. The aim of this study… read more here.
Keywords: intravenous flucloxacillin; flucloxacillin; incidence; hypokalemia ... See more keywords